HEADER OXIDOREDUCTASE 04-FEB-15 4XZI TITLE CRYSTAL STRUCTURE OF HUMAN ALDOSE REDUCTASE COMPLEXED WITH NADP+ AND TITLE 2 JF0049 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALDOSE REDUCTASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: AR,ALDEHYDE REDUCTASE,ALDO-KETO REDUCTASE FAMILY 1 MEMBER COMPND 5 B1; COMPND 6 EC: 1.1.1.21; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: AKR1B1, ALDR1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET15B KEYWDS TIM BARREL, ALDOSE REDUCTASE, OXIDOREDUCTASE, DIABETES, HALOGENATED KEYWDS 2 COMPOUND, CYTOSOLIC EXPDTA X-RAY DIFFRACTION AUTHOR A.COUSIDO-SIAH,F.X.RUIZ,A.MITSCHLER,M.DOMINGUEZ,A.R.DE LERA,J.FARRES, AUTHOR 2 X.PARES,A.PODJARNY REVDAT 3 10-JAN-24 4XZI 1 REMARK REVDAT 2 27-JAN-16 4XZI 1 JRNL REVDAT 1 18-NOV-15 4XZI 0 JRNL AUTH F.X.RUIZ,A.COUSIDO-SIAH,S.PORTE,M.DOMINGUEZ,I.CRESPO, JRNL AUTH 2 C.RECHLIN,A.MITSCHLER,A.R.DE LERA,M.J.MARTIN, JRNL AUTH 3 J.A.DE LA FUENTE,G.KLEBE,X.PARES,J.FARRES,A.PODJARNY JRNL TITL STRUCTURAL DETERMINANTS OF THE SELECTIVITY OF JRNL TITL 2 3-BENZYLURACIL-1-ACETIC ACIDS TOWARD HUMAN ENZYMES ALDOSE JRNL TITL 3 REDUCTASE AND AKR1B10. JRNL REF CHEMMEDCHEM V. 10 1989 2015 JRNL REFN ESSN 1860-7187 JRNL PMID 26549844 JRNL DOI 10.1002/CMDC.201500393 REMARK 2 REMARK 2 RESOLUTION. 2.45 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.8_1069) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.45 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 37.03 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 3 NUMBER OF REFLECTIONS : 12366 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.223 REMARK 3 R VALUE (WORKING SET) : 0.219 REMARK 3 FREE R VALUE : 0.290 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.830 REMARK 3 FREE R VALUE TEST SET COUNT : 597 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 37.0367 - 3.8787 0.99 3058 161 0.1721 0.2183 REMARK 3 2 3.8787 - 3.0792 0.99 2964 152 0.2219 0.3036 REMARK 3 3 3.0792 - 2.6901 0.99 2966 139 0.2990 0.4137 REMARK 3 4 2.6901 - 2.4442 0.94 2781 145 0.3080 0.4429 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.480 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 37.240 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.010 2755 REMARK 3 ANGLE : 1.433 3768 REMARK 3 CHIRALITY : 0.084 410 REMARK 3 PLANARITY : 0.007 473 REMARK 3 DIHEDRAL : 18.823 1047 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4XZI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 04-FEB-15. REMARK 100 THE DEPOSITION ID IS D_1000206402. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-SEP-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06DA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12391 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.450 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 200 DATA REDUNDANCY : 4.200 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.08000 REMARK 200 FOR THE DATA SET : 15.2500 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.45 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.54 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.50 REMARK 200 R MERGE FOR SHELL (I) : 0.35800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.060 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 1US0 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.55 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.30 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10 MM TRIS-HCL, PH 8.0, 20% REMARK 280 POLYETHYLENE GLYCOL, PEG 6000, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 37.03250 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 42.39000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 52.61950 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 37.03250 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 42.39000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 52.61950 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 37.03250 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 42.39000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 52.61950 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 37.03250 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 42.39000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 52.61950 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1200 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13160 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -5.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 510 LIES ON A SPECIAL POSITION. REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 21 8.62 80.44 REMARK 500 ASN A 50 10.43 -148.69 REMARK 500 GLU A 70 -8.88 -53.79 REMARK 500 LYS A 100 61.58 64.70 REMARK 500 LEU A 106 119.43 -163.15 REMARK 500 PRO A 188 -34.68 -37.84 REMARK 500 LEU A 190 83.64 -157.57 REMARK 500 ASP A 277 48.22 -140.93 REMARK 500 PHE A 278 -173.31 -171.16 REMARK 500 LEU A 289 -19.45 -46.78 REMARK 500 ASN A 292 121.89 -38.32 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NAP A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue F49 A 402 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1US0 RELATED DB: PDB DBREF 4XZI A 0 315 UNP P15121 ALDR_HUMAN 1 316 SEQADV 4XZI ILE A 4 UNP P15121 LEU 5 CONFLICT SEQRES 1 A 316 MET ALA SER ARG ILE LEU LEU ASN ASN GLY ALA LYS MET SEQRES 2 A 316 PRO ILE LEU GLY LEU GLY THR TRP LYS SER PRO PRO GLY SEQRES 3 A 316 GLN VAL THR GLU ALA VAL LYS VAL ALA ILE ASP VAL GLY SEQRES 4 A 316 TYR ARG HIS ILE ASP CYS ALA HIS VAL TYR GLN ASN GLU SEQRES 5 A 316 ASN GLU VAL GLY VAL ALA ILE GLN GLU LYS LEU ARG GLU SEQRES 6 A 316 GLN VAL VAL LYS ARG GLU GLU LEU PHE ILE VAL SER LYS SEQRES 7 A 316 LEU TRP CYS THR TYR HIS GLU LYS GLY LEU VAL LYS GLY SEQRES 8 A 316 ALA CYS GLN LYS THR LEU SER ASP LEU LYS LEU ASP TYR SEQRES 9 A 316 LEU ASP LEU TYR LEU ILE HIS TRP PRO THR GLY PHE LYS SEQRES 10 A 316 PRO GLY LYS GLU PHE PHE PRO LEU ASP GLU SER GLY ASN SEQRES 11 A 316 VAL VAL PRO SER ASP THR ASN ILE LEU ASP THR TRP ALA SEQRES 12 A 316 ALA MET GLU GLU LEU VAL ASP GLU GLY LEU VAL LYS ALA SEQRES 13 A 316 ILE GLY ILE SER ASN PHE ASN HIS LEU GLN VAL GLU MET SEQRES 14 A 316 ILE LEU ASN LYS PRO GLY LEU LYS TYR LYS PRO ALA VAL SEQRES 15 A 316 ASN GLN ILE GLU CYS HIS PRO TYR LEU THR GLN GLU LYS SEQRES 16 A 316 LEU ILE GLN TYR CYS GLN SER LYS GLY ILE VAL VAL THR SEQRES 17 A 316 ALA TYR SER PRO LEU GLY SER PRO ASP ARG PRO TRP ALA SEQRES 18 A 316 LYS PRO GLU ASP PRO SER LEU LEU GLU ASP PRO ARG ILE SEQRES 19 A 316 LYS ALA ILE ALA ALA LYS HIS ASN LYS THR THR ALA GLN SEQRES 20 A 316 VAL LEU ILE ARG PHE PRO MET GLN ARG ASN LEU VAL VAL SEQRES 21 A 316 ILE PRO LYS SER VAL THR PRO GLU ARG ILE ALA GLU ASN SEQRES 22 A 316 PHE LYS VAL PHE ASP PHE GLU LEU SER SER GLN ASP MET SEQRES 23 A 316 THR THR LEU LEU SER TYR ASN ARG ASN TRP ARG VAL CYS SEQRES 24 A 316 ALA LEU LEU SER CYS THR SER HIS LYS ASP TYR PRO PHE SEQRES 25 A 316 HIS GLU GLU PHE HET NAP A 401 48 HET F49 A 402 50 HETNAM NAP NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE HETNAM F49 [2,4-DIOXO-3-(2,3,4,5-TETRABROMO-6-METHOXYBENZYL)-3,4- HETNAM 2 F49 DIHYDROPYRIMIDIN-1(2H)-YL]ACETIC ACID HETSYN NAP 2'-MONOPHOSPHOADENOSINE 5'-DIPHOSPHORIBOSE FORMUL 2 NAP C21 H28 N7 O17 P3 FORMUL 3 F49 C14 H10 BR4 N2 O5 FORMUL 4 HOH *38(H2 O) HELIX 1 AA1 PRO A 23 GLY A 38 1 16 HELIX 2 AA2 ALA A 45 GLN A 49 5 5 HELIX 3 AA3 ASN A 50 ARG A 63 1 14 HELIX 4 AA4 LYS A 68 LEU A 72 5 5 HELIX 5 AA5 TRP A 79 HIS A 83 5 5 HELIX 6 AA6 GLU A 84 GLY A 86 5 3 HELIX 7 AA7 LEU A 87 LYS A 100 1 14 HELIX 8 AA8 ASN A 136 GLU A 150 1 15 HELIX 9 AA9 ASN A 162 ASN A 171 1 10 HELIX 10 AB1 GLN A 192 LYS A 202 1 11 HELIX 11 AB2 SER A 226 GLU A 229 5 4 HELIX 12 AB3 ASP A 230 ASN A 241 1 12 HELIX 13 AB4 THR A 243 GLN A 254 1 12 HELIX 14 AB5 THR A 265 ASN A 272 1 8 HELIX 15 AB6 SER A 281 SER A 290 1 10 HELIX 16 AB7 LEU A 300 THR A 304 5 5 SHEET 1 AA1 2 ARG A 3 LEU A 5 0 SHEET 2 AA1 2 LYS A 11 PRO A 13 -1 O MET A 12 N ILE A 4 SHEET 1 AA2 8 LEU A 17 GLY A 18 0 SHEET 2 AA2 8 HIS A 41 ASP A 43 1 O HIS A 41 N LEU A 17 SHEET 3 AA2 8 PHE A 73 LEU A 78 1 O VAL A 75 N ILE A 42 SHEET 4 AA2 8 LEU A 106 ILE A 109 1 O LEU A 108 N LEU A 78 SHEET 5 AA2 8 ILE A 156 SER A 159 1 O GLY A 157 N TYR A 107 SHEET 6 AA2 8 VAL A 181 GLU A 185 1 O GLN A 183 N ILE A 158 SHEET 7 AA2 8 VAL A 205 TYR A 209 1 O TYR A 209 N ILE A 184 SHEET 8 AA2 8 VAL A 258 VAL A 259 1 O VAL A 258 N ALA A 208 SITE 1 AC1 28 GLY A 18 THR A 19 TRP A 20 LYS A 21 SITE 2 AC1 28 ASP A 43 TYR A 48 HIS A 110 TRP A 111 SITE 3 AC1 28 SER A 159 ASN A 160 GLN A 183 TYR A 209 SITE 4 AC1 28 SER A 210 PRO A 211 LEU A 212 GLY A 213 SITE 5 AC1 28 SER A 214 ASP A 216 ILE A 260 PRO A 261 SITE 6 AC1 28 LYS A 262 SER A 263 VAL A 264 THR A 265 SITE 7 AC1 28 ARG A 268 GLU A 271 ASN A 272 F49 A 402 SITE 1 AC2 18 TRP A 20 VAL A 47 TYR A 48 GLN A 49 SITE 2 AC2 18 TRP A 79 HIS A 110 TRP A 111 PHE A 121 SITE 3 AC2 18 PHE A 122 ASP A 125 GLU A 126 SER A 127 SITE 4 AC2 18 GLY A 128 TRP A 219 CYS A 298 LEU A 300 SITE 5 AC2 18 SER A 302 NAP A 401 CRYST1 74.065 84.780 105.239 90.00 90.00 90.00 I 2 2 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013502 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011795 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009502 0.00000